2.3400
-0.0100
(-0.43%)
As of 11:54:37 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-35,886.0000
-34,113.0000
-22,691.0000
-28,320.0000
Investing Cash Flow
--
35,510.0000
37,060.0000
6,616.0000
-82,172.0000
Financing Cash Flow
--
3,081.0000
353.0000
16,838.0000
108,463.0000
End Cash Position
--
14,255.0000
11,421.0000
8,514.0000
7,810.0000
Interest Paid Supplemental Data
--
3,052.0000
852.0000
1,364.0000
1,232.0000
Capital Expenditure
--
-172.0000
-487.0000
-292.0000
-166.0000
Issuance of Capital Stock
--
3,081.0000
--
14,958.0000
74,147.0000
Free Cash Flow
--
-36,058.0000
-34,600.0000
-22,983.0000
-28,486.0000
12/31/2020 - 8/11/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVGN Evogene Ltd.
1.5710
+1.35%
RCUS Arcus Biosciences, Inc.
13.45
+0.49%
ENLV Enlivex Therapeutics Ltd.
1.0987
-1.02%
MDWD MediWound Ltd.
19.60
-1.41%
LTRN Lantern Pharma Inc.
5.0000
+3.95%
PLUR Pluri Inc.
4.3001
-1.82%
PLX Protalix BioTherapeutics, Inc.
2.4200
+1.68%
BLRX BioLineRx Ltd.
3.3300
-6.72%
LCTX Lineage Cell Therapeutics, Inc.
0.6590
+5.18%
DOMH Dominari Holdings Inc.
3.3802
-5.58%